AdvaMed

Olympus Corporation of the Americas' Julien Sauvagnargues Steps into CEO Role

Retrieved on: 
Wednesday, March 27, 2024
Grifols, Nachos, Olympus Corporation, AdvaMed, OCA, CSO, Medtech, Corporation, Management

CENTER VALLEY, Pa., March 27, 2024 /PRNewswire/ -- Olympus, a leading global MedTech company providing innovative solutions for medical and surgical procedures, announced today the appointment of Julien Sauvagnargues to the role of President and Chief Executive Officer (CEO), Olympus Corporation of the Americas (OCA), reporting to Olympus Chief Strategy Officer (CSO), Gabriela Kaynor, effective April 1, 2024.

Key Points: 
  • This new step in Mr. Sauvagnargues' career at Olympus, which began in 2006, builds upon his tenure as OCA President since 2020.
  • Mr. Glavin came to Olympus in 2016 in a consultant role and became the OCA Chief Compliance Officer that same year.
  • These leadership changes are in part due to the departure from Olympus of Nacho Abia, former OCA CEO and global CSO.
  • "We cannot be grateful enough for Nacho's 23-year tenure with this company," said Stefan Kaufmann, CEO, Olympus Corporation.

GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

Retrieved on: 
Tuesday, January 23, 2024
Patient, Policy, Moyamoya disease, AdvaMed, Committee, Mentorship, Strategic planning, Medtronic, Boston Scientific, Organization, EVP

TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately.

Key Points: 
  • TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ: GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately.
  • Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee.
  • Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments.
  • She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-potential leaders.

Olympus Earns High Marks in Human Rights Campaign Foundation's Corporate Equality Index

Retrieved on: 
Wednesday, January 17, 2024
Patient, Legislation, Policy, AdvaMed, Human Rights Campaign, DEI, Environment, Gender identity, CEI, Rashawn, Workforce, Corporate Equality Index, Inclusion, OCA, Single person, Management

CENTER VALLEY, Pa. , Jan. 17, 2024 /PRNewswire/ -- Olympus Corp. of the Americas (OCA), a global medical technology company, announced today that it received a score of 90 out of 100 on the Human Rights Campaign Foundation's 2023-24 Corporate Equality Index (CEI). The CEI serves as the nation's foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality. OCA joins more than 1,300 major U.S. businesses that were also ranked in the 2023-24 CEI.

Key Points: 
  • CENTER VALLEY, Pa. , Jan. 17, 2024 /PRNewswire/ -- Olympus Corp. of the Americas (OCA), a global medical technology company, announced today that it received a score of 90 out of 100 on the Human Rights Campaign Foundation's 2023-24 Corporate Equality Index (CEI).
  • The CEI serves as the nation's foremost benchmarking survey and report measuring corporate policies and practices related to LGBTQ+ workplace equality.
  • "We're honored to be recognized by the Human Rights Campaign Foundation for the second consecutive time on an LGBTQ+ index that continues to raise the bar," said Danielle Gruppo, Director of Diversity Equity and Inclusion and HR Compliance for OCA.
  • "For well over two decades, businesses have played an important role in furthering LGBTQ+ equality by centering employee needs and voices when it comes to workplace inclusion," said RaShawn "Shawnie" Hawkins, Human Rights Campaign Senior Director of Workplace Equality.

BioStem Technologies Bolsters Leadership with Appointment of Thomas Dugan to Board of Directors

Retrieved on: 
Wednesday, December 13, 2023
AdvaMed, Portable ultrasound, Wound healing, Regenerative medicine, Smith, Amputation, Face, Wound, Growth, OTC, Covidien, MITA, Management

(OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.

Key Points: 
  • (OTC:BSEM), a leading regenerative medicine company focused on the development, manufacture, and commercialization of placental-derived biologics for advanced wound care, today announces the appointment of Mr. Thomas J. Dugan to the position of Chairman of the Board.
  • Mr. Dugan brings a wealth of experience to BioStem, with proven, hands-on expertise as a senior executive who has transformed businesses, established new market opportunities, and driven growth in the face of strong competition.
  • BioStem Technologies CEO, Jason Matuszewski, said, “I am delighted to welcome Mr. Dugan to BioStem’s Board of Directors.
  • Mr. Dugan served on the board of directors of Rita Medical Systems (NASDAQ: RITA), which was acquired by AngioDynamics, and various venture-backed medical device companies.

MeMed Further Solidifies Board of Directors Appointing Scott Garrett

Retrieved on: 
Thursday, November 9, 2023
Water, MA, AdvaMed, Dade Behring, Health, Senior, Internet meme, Growth, Baxter International, Water Street, Minerva Surgical, Inc. v. Hologic, Inc., Beckman Coulter, Management

HAIFA, Israel; BOSTON, MA – 9 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Scott Garrett to its Board of Directors.

Key Points: 
  • HAIFA, Israel; BOSTON, MA – 9 November, 2023 – MeMed, a leader in host response technologies, today announces the appointment of Scott Garrett to its Board of Directors.
  • Scott Garrett is currently a Senior Operating Partner at Water Street Healthcare Partners, a private equity firm focused solely on healthcare investments.
  • I'm truly enthusiastic about my appointment to MeMed's Board of Directors and eagerly anticipate helping the MeMed team achieve its operational and strategic goals.”
    Dr. Eran Eden, CEO of MeMed, noted, “We’re excited to welcome Scott Garrett to our Board and leadership team.
  • I look forward to working with Scott to further our mission and establish MeMed as a leader in the emerging field of advanced host-response.”

Co-Diagnostics, Inc. Shares List of Upcoming Industry Conferences and Events for November 2023

Retrieved on: 
Tuesday, October 31, 2023
MEDICA, FDA, Research, Sale, Exhibition, CSO, AMP, Journal of NIH Research, International Workshop on Lung Health, Conference, PCR, Health, SALT, Union, AdvaMed, Pharmaceutical industry, Medical device, Booth

Utah Life Sciences Summit in Salt Lake City; Nov. 9, 2023: This event will feature leading experts in the life sciences industry gathered from around the country.

Key Points: 
  • Utah Life Sciences Summit in Salt Lake City; Nov. 9, 2023: This event will feature leading experts in the life sciences industry gathered from around the country.
  • "A study by Advamed ranked Utah as #8 in the country for production of medical devices and #9 for total employees in the medical device space."
  • AMP in Salt Lake City; Nov. 14-18, 2023: The Association for Molecular Pathology (AMP) is a leading organization in the field of molecular diagnostics.
  • Co-Dx CEO Dwight Egan will also be giving an innovation spotlight presentation on Stage #1 at 9:30-10:30 AM MT on November 17, 2023.

Day Zero Diagnostics Names Jeff Mirviss Chair of Board of Directors

Retrieved on: 
Tuesday, October 24, 2023
Government, AdvaMed, State Government Affairs Council, Infection, Health, Central Executive Committee of the Pakistan Peoples Party, Marketing, Executive Committee, DZD, Independent Board for Presbyterian Foreign Missions, Management, Boston Scientific

BOSTON, Oct. 24, 2023 /PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today that independent board member, Jeff Mirviss, has been appointed board chair.

Key Points: 
  • BOSTON, Oct. 24, 2023 /PRNewswire/ -- Day Zero Diagnostics Inc. (DZD), an infectious disease diagnostics company harnessing the power of whole-genome sequencing and AI to combat the rise of antibiotic-resistant infections, announced today that independent board member, Jeff Mirviss, has been appointed board chair.
  • "Jeff has been an important advisor, investor and supporter of DZD since the early days of our company and the company has benefitted greatly from his involvement and counsel," said Jong Lee, CEO and co-founder, Day Zero Diagnostics.
  • Outside of Boston Scientific, Mr. Mirviss serves on the Executive Board of AdvaMed, the industry association for medtech and diagnostic companies.
  • "I'm honored to be elected chair of the Day Zero Diagnostics Board of Directors and look forward to continuing to work with my colleagues on the Board, as well as the visionary team at DZD," said Jeff Mirviss, chair, DZD Board of Directors.

Johnson & Johnson Announces Departure of Ashley McEvoy, Tim Schmid Named Executive Vice President, Worldwide Chairman of MedTech

Retrieved on: 
Monday, October 23, 2023
Biotechnology, Pharmaceutical, Health, Medical Devices, Live Company Group, Worldwide, AdvaMed, Credo, NYSE, Medtech, McNeil Consumer Healthcare, JNJ, CHOP, Joaquin Duato, Trustee, Lead, Johnson & Johnson, Patient, Management

Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities.

Key Points: 
  • Johnson & Johnson (NYSE: JNJ) (the Company) announced today that Ashley McEvoy, Executive Vice President, Worldwide Chairman of MedTech, informed the company on October 20, 2023, that she is stepping down from her position to pursue other opportunities.
  • Tim Schmid has been appointed Executive Vice President, Worldwide Chairman of MedTech, joining the Company’s Executive Committee.
  • “I want to thank Ashley for her leadership and 27 years of service at Johnson & Johnson.
  • With 30 years of Johnson & Johnson experience, Mr. Schmid most recently served as the Company Group Chairman of Johnson & Johnson MedTech Asia Pacific (APAC).

MedTech Innovator Names StrokeDx as 2023 Global Competition Winner at The MedTech Conference

Retrieved on: 
Wednesday, October 11, 2023
General Health, Health Technology, Health, Medical Devices, Olympus Corporation, Medtech, Quality of life, Algorithm, Zimmer Biomet, MTEC, Stroke, Wilson Sonsini Goodrich & Rosati, Cambridge Consultants, Johnson & Johnson, Patient, SVP, Global Competitiveness Report, Feedback, American Society of Plastic Surgeons, ASPS, NAMSA, FDA, Plastic, Business development, AdvaMed, InterSystems, Growth, MTI, Conference, Pharmaceutical industry, Capgemini, Dexcom, Final

MedTech Innovator , the world’s largest accelerator of medical technology companies, today announced that StrokeDx is the winner of its 2023 Global Competition.

Key Points: 
  • MedTech Innovator , the world’s largest accelerator of medical technology companies, today announced that StrokeDx is the winner of its 2023 Global Competition.
  • From among five finalists in the 2023 cohort, the winner was determined by a live audience vote during The MedTech Conference , powered by AdvaMed, on October 10.
  • Two hundred companies were invited to pitch during the MedTech Innovator Road Tour, with 61 companies ultimately participating in the 2023 Cohort.
  • “The MedTech Innovator program has been incredible, and its impact on our company for years to come will be significant,” said Alexander Ballatori, co-founder and CEO, StrokeDx.

FDA awards nearly $7.5 million to pediatric device consortium led by Children’s National Hospital

Retrieved on: 
Tuesday, September 19, 2023
Walter Reed Army Medical Center, Therapy, Report of the 1st Annual Symposium on Relaxed Improvisation, Elective surgery, University, FDA Center for Devices and Radiological Health, Research, African Americans, Food and Drug Administration Amendments Act of 2007, Acquisition, PDC, Tufts Medical Center, Johns Hopkins University, Mass, Mass General Brigham, AdvaMed, RWE, World Creativity and Innovation Day, Ecosystem, FDA, Health, Device, Conference, Food, Harwell Science and Innovation Campus, Birth control, Pharmaceutical industry

WASHINGTON, D.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- To foster the development and commercialization of medical devices designed for children, the Food and Drug Administration (FDA) has awarded a nearly $7.5 million grant to the Alliance for Pediatric Device Innovation (APDI), a consortium led by Children’s National Hospital .

Key Points: 
  • WASHINGTON, D.C., Sept. 19, 2023 (GLOBE NEWSWIRE) -- To foster the development and commercialization of medical devices designed for children, the Food and Drug Administration (FDA) has awarded a nearly $7.5 million grant to the Alliance for Pediatric Device Innovation (APDI), a consortium led by Children’s National Hospital .
  • New in this cycle, APDI will provide expertise on evidence generation, including the use of real-world evidence (RWE), for pediatric device development.
  • Along with Children’s National, APDI consortium members include Johns Hopkins University, CIMIT at Mass General Brigham, Tufts Medical Center and Medstar Health Research Institute.
  • Eskandanian says the new Children’s National Research and Innovation Campus provides the ideal environment for the collaborative work needed to advance pediatric innovation.